Liquid Biopsy Market

Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach at $3, 805 million by 2023, registering a CAGR of 28.9% from 2017 to 2023.

Get The Sample Copy of This Report @ https://www.bigmarketresearch.com/request-sample/1169135?utm_source=op&utm_medium=Srbh

KEY PLAYERS PROFILED : Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC., Trovagene Inc., Guardant Health Inc., GRAIL, MDX Health SA
Other Key Players : Fraunhofer-Gesellschaft, Horizon Discovery, Illumina, Inc., Cynvenio, Diagnologix, Exosome Sciences, CyoTrack (profiles not included in the report)

The report offers an in-depth analysis of major-winning strategies, varying dynamics, regional landscape, current market size & forecast, and market competition. It provides analysis of the key raw materials, key suppliers of raw materials, manufacturing cost analysis, and labor cost analysis.
The report presents the industry Definition, Specification, and Categorization while inspecting the market overview. market dynamics such as market driving factors, upcoming investment opportunities, contemporary market trends, threats, challenges, and constraints are also evaluated in this studyLiquid biopsy is a simple and precise alternative to surgical biopsies, which allows physicians & surgeons to detect & treat cancer at an early stage and acquire tumor information through blood samples. These biopsies are particularly significant as they help the physician to understand the molecular changes and dynamics of cancer. Moreover, cancer recurrence is expected to be understood through well-timed liquid biopsies.

The report offers in-depth analysis of the current market trends that drive the growth of the market along with an analysis of the future market potential. The study provides market status and outlook from the point of view of market players, end industries, regions, and product types.
Surge in prevalence of cancer, advantages of liquid biopsy over solid tumor biopsy, rise in awareness about minimally invasive procedures, and favorable government initiatives supplement the market growth. However, alternatives to liquid biopsies and unclear reimbursement & regulation scenario impede the growth. Furthermore, increase in pre-screening programs for cancer detection provide lucrative opportunity for the market players.

Do Needful Purchase Inquiry @ https://www.bigmarketresearch.com/purchase-enquiry/1169135?utm_source=op&utm_medium=Srbh

The liquid biopsy market is segmented based on product & service, cancer type, circulating biomarker, end user, and geography.
Based on product & service, it is divided into reagents, instruments, and services. On the basis cancer type, it is classified into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancer. According to circulating biomarkers, it is categorized into circulating tumor cell, extracellular vesicle, circulating tumor DNA [ctDNA], and other biomarkers. On the basis of end user, it is classified into hospital & laboratory and government & research centers. Geographically, it is analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global liquid biopsy market and the current trends and future estimations to elucidate the imminent investment pockets.

The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on cancer types assists to understand the trends in the industry.

Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Get purchase Discount @ https://www.bigmarketresearch.com/request-for-discount/1169135?utm_source=op&utm_medium=Srbh

About Us:

Big Market Research has a range of research reports from various publishers across the world.
Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact Us:

Mr. Abhishek Paliwal
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Direct:+1-971-202-1575
Toll Free:+1-800-910-6452
email help@bigmarketresearch.com

This release was published on openPR.